An Experiment in Helping Foster-Carers Manage Challenging Behaviour
In: The British journal of social work, Band 35, Heft 8, S. 1265-1282
ISSN: 1468-263X
10 Ergebnisse
Sortierung:
In: The British journal of social work, Band 35, Heft 8, S. 1265-1282
ISSN: 1468-263X
In: African affairs: the journal of the Royal African Society, Band 52, Heft 208, S. 251-252
ISSN: 1468-2621
In: African affairs: the journal of the Royal African Society, Band 44, Heft 177, S. 171-176
ISSN: 1468-2621
In: The British journal of social work, Band 40, Heft 4, S. 1174-1191
ISSN: 1468-263X
In: Social work: a journal of the National Association of Social Workers, Band 46, Heft 2, S. 107-114
ISSN: 1545-6846
In: Regional studies: official journal of the Regional Studies Association, Band 48, Heft 8
ISSN: 1360-0591
In: Regional studies: official journal of the Regional Studies Association, Band 48, Heft 8, S. 1419-1433
ISSN: 1360-0591
BACKGROUND: Angiotensin-converting-enzyme (ACE) inhibitor therapy can significantly delay the progression of diabetic nephropathy to end-stage renal failure (ESRF). The main obstacle to successful compliance with this therapy is the cost to the patients. The authors performed a cost-utility analysis from the government's perspective to see whether the province or territory should pay for ACE inhibitors for type I diabetic nephropathy on the assumption that cost is a major barrier to compliance with this important therapy. METHODS: A decision analysis tree was created to demonstrate the progression of type I diabetes with macroproteinuria from the point of prescription of ACE inhibitor therapy through to ESRF management, with a 21-year follow-up. Drug compliance, cost of ESRF treatment, utilities and survival data were taken from Canadian sources and used in the cost-utility analysis. One-way and two-way sensitivity analyses were performed to test the robustness of the findings. RESULTS: Compared with a no-payment strategy, provincial payment of ACE inhibitor therapy was found to be highly cost-effective: it resulted in an increase of 0.147 in the number of quality-adjusted life-years (QALYs) and an annual cost savings of $849 per patient. The sensitivity analyses indicated that the cost-effectiveness depends on compliance, effect of benefit and the cost of drug therapy. Changes in the compliance rate from 67% to 51% could result in a swing in cost-effectiveness from a savings of $899 to an expenditure of more than $1 million per additional QALY. A 50% reduction in the cost of ACE inhibitors would result in a cost savings of $299 per additional QALY with compliance rates as low as 58% in the provincial payment strategy. INTERPRETATION: Provincial coverage of ACE inhibitor therapy for type I diabetes with macroproteinuria improves patient outcomes, with a decrease in cost for ESRF services.
BASE
In: The British journal of social work, Band 43, Heft 5, S. 1024-1038
ISSN: 1468-263X
This is the final version. Available on open access from the National Academy of Sciences via the DOI in this record ; Data Availability. The results and peat core data are summarized in Datasets S1–S6. Maps of predicted peatland extent, peat depth, and peat C and N storage (10-km pixels) are archived and freely available for download at https://bolin.su.se/data/hugelius-2020 ; Northern peatlands have accumulated large stocks of organic carbon (C) and nitrogen (N), but their spatial distribution and vulnerability to climate warming remain uncertain. Here, we used machine-learning techniques with extensive peat core data (n > 7,000) to create observation-based maps of northern peatland C and N stocks, and to assess their response to warming and permafrost thaw. We estimate that northern peatlands cover 3.7 ± 0.5 million km2 and store 415 ± 150 Pg C and 10 ± 7 Pg N. Nearly half of the peatland area and peat C stocks are permafrost affected. Using modeled global warming stabilization scenarios (from 1.5 to 6 °C warming), we project that the current sink of atmospheric C (0.10 ± 0.02 Pg C⋅y-1) in northern peatlands will shift to a C source as 0.8 to 1.9 million km2 of permafrost-affected peatlands thaw. The projected thaw would cause peatland greenhouse gas emissions equal to ∼1% of anthropogenic radiative forcing in this century. The main forcing is from methane emissions (0.7 to 3 Pg cumulative CH4-C) with smaller carbon dioxide forcing (1 to 2 Pg CO2-C) and minor nitrous oxide losses. We project that initial CO2-C losses reverse after ∼200 y, as warming strengthens peatland C-sinks. We project substantial, but highly uncertain, additional losses of peat into fluvial systems of 10 to 30 Pg C and 0.4 to 0.9 Pg N. The combined gaseous and fluvial peatland C loss estimated here adds 30 to 50% onto previous estimates of permafrost-thaw C losses, with southern permafrost regions being the most vulnerable. ; Swedish Research Council ; European Union ; European Union Horizon 2020 ; Gordon and Betty and Gordon Moore Foundation ; Natural Environment Research Council (NERC) ; National Science Foundation ; National Natural Science Foundation of China
BASE